<?xml version="1.0" encoding="UTF-8"?>
<ref id="B3">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Chapman</surname>
    <given-names>K. R.</given-names>
   </name>
   <name>
    <surname>Burdon</surname>
    <given-names>J. G. W.</given-names>
   </name>
   <name>
    <surname>Piitulainen</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Sandhaus</surname>
    <given-names>R. A.</given-names>
   </name>
   <name>
    <surname>Seersholm</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Stocks</surname>
    <given-names>J. M.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2015</year>). 
  <article-title>Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial</article-title>. 
  <source>The Lancet</source>
  <volume>386</volume>, 
  <fpage>360</fpage>–
  <lpage>368</lpage>. 
  <pub-id pub-id-type="doi">10.1016/S0140-6736(15)60860-1</pub-id>
 </mixed-citation>
</ref>
